Notice: Get a jump on 2015 — Pay your 2015 ASA membership dues now!

>

MEETINGS / EVENTS

RSS

January 23 - 25 2015, 12:00 AM - 12:00 AM

ASA PRACTICE MANAGEMENT 2015

February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

June 26 - 28 2015, 12:00 AM - 12:00 AM

Annual Perioperative Surgical Home Summit

>

FDA MEDWATCH ALERTS

December 18, 2014

0.9 Percent Sodium Chloride Injection USP in 100 mL MINI-BAG PLUS Container by Baxter: Recall - Particulate Matter

Summary:

FDA MedWatch Recall - Particulate Matter

November 21, 2014

FDA MedWatch - Respironics California, Esprit V1000 and V200 Ventilators: Class I Recall - Power Failure May Occur

Summary:

FDA MedWatch Respironics California Esprit V1000 and V200 Ventilators Class I Recall

November 21, 2014

FDA MedWatch - Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL by Baxter: Recall - Mislabeled

Summary:

Highly Concentrated Potassium Chloride Injection 10 mEq per 100 mL by Baxter Recall Mislabeled

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

IPAB Elimination Legislation Introduced

Friday, January 28, 2011

Representative Phil Roe, M.D., (R-TN) has introduced H.R. 452, legislation that would eliminate the Independent Payment Advisory Board (IPAB) from the Patient Protection and Affordable Care Act (PPACA). The legislation currently has 23 cosponsors. ASA strongly opposes the IPAB - a draconian Medicare cost-cutting mechanism created by PPACA.

The reform law created the IPAB as a novel and aggressive mechanism to “reduce the per capita rate of growth in Medicare spending.” The Board, composed of 15 members appointed by the President, is charged with developing proposals to maintain Medicare spending below a targeted per capita growth rate.  The Board’s proposals receive special expedited and protected consideration by Congress. The process spelled out in the statute creates a number of barriers that inhibit Congress’ ability to reject or defeat any proposed Medicare cuts.   

ASA is extremely troubled by the prospect of sweeping cuts to already unreasonably low Medicare payments for anesthesia services. Cuts by IPAB will have a disproportionate impact on anesthesia services because of the already low payment rates.

In December 2009, Democrats and Republicans wrote a letter to Nancy Pelosi, expressing strong opposition to IPAB.

Dr. Phil Roe released the following statements on IPAB:

"The creation of the IPAB is a flawed mandate in Obamacare that must be repealed. This board’s sole purpose is to control Medicare costs – giving this board the authority to approve and deny funding for care. The IPAB does not have a mandate to improve patient care, but simply to meet a budget. Naturally, my concern is that this board will harm patient care."

"In addition, the IPAB will lack full Congressional Oversight, compromising its accountability to the American people. This simply cannot be allowed to happen. We have bipartisan agreement around the idea that unelected bureaucrats shouldn't be able to make unaccountable decisions."

Click here to read the full legislation. 

 

« Back to Washington Alerts